251 related articles for article (PubMed ID: 19300402)
1. Bradykinin receptors antagonists and nitric oxide synthase inhibitors in vincristine and streptozotocin induced hyperalgesia in chemotherapy and diabetic neuropathy rat model.
Bujalska M; Makulska-Nowak H
Neuro Endocrinol Lett; 2009 Mar; 30(1):144-52. PubMed ID: 19300402
[TBL] [Abstract][Full Text] [Related]
2. Effect of bradykinin receptor antagonists on vincristine- and streptozotocin-induced hyperalgesia in a rat model of chemotherapy-induced and diabetic neuropathy.
Bujalska M; Tatarkiewicz J; Gumułka SW
Pharmacology; 2008; 81(2):158-63. PubMed ID: 17989505
[TBL] [Abstract][Full Text] [Related]
3. Bradykinin receptor antagonists and cyclooxygenase inhibitors in vincristine- and streptozotocin-induced hyperalgesia.
Bujalska M; Makulska-Nowak H
Pharmacol Rep; 2009; 61(4):631-40. PubMed ID: 19815945
[TBL] [Abstract][Full Text] [Related]
4. Influence of nitric oxide synthase or cyclooxygenase inhibitors on cannabinoids activity in streptozotocin-induced neuropathy.
Bujalska-Zadrożny M; de Cordé A; Pawlik K
Pharmacol Rep; 2015 Apr; 67(2):209-16. PubMed ID: 25712641
[TBL] [Abstract][Full Text] [Related]
5. Involvement of bradykinin B1 and B2 receptors in relaxation of mouse isolated trachea.
Li L; Vaali K; Paakkari I; Vapaatalo H
Br J Pharmacol; 1998 Apr; 123(7):1337-42. PubMed ID: 9579728
[TBL] [Abstract][Full Text] [Related]
6. Evidence for participation of B1 and B2 kinin receptors in formalin-induced nociceptive response in the mouse.
Corrêa CR; Calixto JB
Br J Pharmacol; 1993 Sep; 110(1):193-8. PubMed ID: 8220879
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of different fractions of Calotropis procera (Asclepiadaceae) in streptozotocin induced experimental model of diabetic neuropathy.
Yadav SK; Nagori BP; Desai PK
J Ethnopharmacol; 2014 Mar; 152(2):349-57. PubMed ID: 24486599
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the peripheral mediator background of heat injury- and plantar incision-induced drop of the noxious heat threshold in the rat.
Füredi R; Bölcskei K; Szolcsányi J; Petho G
Life Sci; 2010 Feb; 86(7-8):244-50. PubMed ID: 20036261
[TBL] [Abstract][Full Text] [Related]
9. Effect of selol on the opioids activity in streptozotocin induced hyperalgesia.
Bujalska M; Winecka R; Gumułka SW
Acta Pol Pharm; 2008; 65(6):691-6. PubMed ID: 19172850
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of type 1 diabetic hyperalgesia in streptozotocin-induced Wistar versus spontaneous gene-prone BB/Worchester rats: efficacy of a selective bradykinin B1 receptor antagonist.
Gabra BH; Benrezzak O; Pheng LH; Duta D; Daull P; Sirois P; Nantel F; Battistini B
J Neuropathol Exp Neurol; 2005 Sep; 64(9):782-9. PubMed ID: 16141788
[TBL] [Abstract][Full Text] [Related]
11. Antinociceptive activity of the bradykinin B1 and B2 receptor antagonists, des-Arg9, [Leu8]-BK and HOE 140, in two models of persistent hyperalgesia in the rat.
Perkins MN; Campbell E; Dray A
Pain; 1993 May; 53(2):191-197. PubMed ID: 8393171
[TBL] [Abstract][Full Text] [Related]
12. Effect of cyclooxygenase and nitric oxide synthase inhibitors on streptozotocin-induced hyperalgesia in rats.
Bujalska M; Tatarkiewicz J; de Cordé A; Gumułka SW
Pharmacology; 2008; 81(2):151-7. PubMed ID: 17989504
[TBL] [Abstract][Full Text] [Related]
13. Bradykinin-induced knee joint incapacitation involves bradykinin B2 receptor mediated hyperalgesia and bradykinin B1 receptor-mediated nociception.
Tonussi CR; Ferreira SH
Eur J Pharmacol; 1997 May; 326(1):61-5. PubMed ID: 9178656
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the receptor and the mechanisms underlying the inflammatory response induced by des-Arg9-BK in mouse pleurisy.
Vianna RM; Calixto JB
Br J Pharmacol; 1998 Jan; 123(2):281-91. PubMed ID: 9489617
[TBL] [Abstract][Full Text] [Related]
15. Effect of cyclooxygenase and nitric oxide synthase inhibitors on vincristine induced hyperalgesia in rats.
Bujalska M; Gumułka SW
Pharmacol Rep; 2008; 60(5):735-41. PubMed ID: 19066421
[TBL] [Abstract][Full Text] [Related]
16. Role of bradykinin B(1) receptors in diabetes-induced hyperalgesia in streptozotocin-treated mice.
Gabra BH; Sirois P
Eur J Pharmacol; 2002 Dec; 457(2-3):115-24. PubMed ID: 12464357
[TBL] [Abstract][Full Text] [Related]
17. Bradykinin dilates rat middle cerebral artery and its large branches via endothelial B2 receptors and release of nitric oxide.
Görlach C; Wahl M
Peptides; 1996; 17(8):1373-8. PubMed ID: 8971934
[TBL] [Abstract][Full Text] [Related]
18. The induction of des-Arg9-bradykinin-mediated hyperalgesia in the rat by inflammatory stimuli.
Davis AJ; Kelly D; Perkins MN
Braz J Med Biol Res; 1994 Aug; 27(8):1793-802. PubMed ID: 7749369
[TBL] [Abstract][Full Text] [Related]
19. Effect of cannabinoid receptor agonists on streptozotocin-induced hyperalgesia in diabetic neuropathy.
Bujalska M
Pharmacology; 2008; 82(3):193-200. PubMed ID: 18810243
[TBL] [Abstract][Full Text] [Related]
20. Effect of dexamethasone on cyclophosphamide-induced cystitis in rats: lack of relation with bradykinin B1 receptor-mediated motor responses.
Lecci A; Meini S; Patacchini R; Tramontana M; Giuliani S; Criscuoli M; Maggi CA
Eur J Pharmacol; 1999 Mar; 369(1):99-106. PubMed ID: 10204687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
